Associate Professor and Director or Experimental TherapeuticsNationwide Children's HospitalColumbus, Ohio, United States
OC 38.2 - Acquired Abnormalities in the Hemostatic System During Induction Chemotherapy in Treatment of Childhood Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-study of the PREVAPIX-ALL Trial
Monday, June 26, 202311:00 – 11:15 ET
OC 38.3 - Effects of Apixaban Versus No Anticoagulation on Biomarkers of Thrombin Generation in Pediatric Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-study of PREVAPIX-ALL, a Randomized Controlled Trial
Monday, June 26, 202311:15 – 11:30 ET
